- Home
- BTAI vs SVRN Comparison
BTAI vs SVRN Comparison
Compare BTAI & SVRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | SVRN |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 46.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTAI | SVRN |
|---|---|---|
| Price | $1.87 | $1.10 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 540.0K | 101.3K |
| Earning Date | 11-12-2025 | 12-02-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $752,000.00 | ★ $19,435,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $416.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $1.01 |
| 52 Week High | $9.26 | $79.25 |
Technical Indicators
Market Signals| Indicator | BTAI | SVRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | N/A |
| Support Level | $1.82 | N/A |
| Resistance Level | $2.30 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.83 | 0.00 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About SVRN OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.